GSK, Pfizer RSV vaccine sales fall in US
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Pfizer is looking to use AI in a Singapore initiative to shorten the drug discovery process. Read more at straitstimes.com.
There aren’t a lot of easy changes the drugmaker can make to right itself quickly. Boosting sales fast enough to lift shares will be hard, and high debts rule out a game-changing acquisition. Get the ...
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating yesterday. David Risinger has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback